1. Home
  2. AMH vs PRAX Comparison

AMH vs PRAX Comparison

Compare AMH & PRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo American Homes 4 Rent of Beneficial Interest

AMH

American Homes 4 Rent of Beneficial Interest

HOLD

Current Price

$31.13

Market Cap

11.3B

Sector

Real Estate

ML Signal

HOLD

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$342.77

Market Cap

9.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMH
PRAX
Founded
2012
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.3B
9.6B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
AMH
PRAX
Price
$31.13
$342.77
Analyst Decision
Hold
Strong Buy
Analyst Count
19
15
Target Price
$34.86
$572.13
AVG Volume (30 Days)
2.7M
381.1K
Earning Date
05-06-2026
05-08-2026
Dividend Yield
4.30%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$2.69
N/A
Revenue Next Year
$2.26
$6,395.88
P/E Ratio
$26.59
N/A
Revenue Growth
N/A
N/A
52 Week Low
$27.22
$34.89
52 Week High
$39.49
$354.87

Technical Indicators

Market Signals
Indicator
AMH
PRAX
Relative Strength Index (RSI) 71.75 59.58
Support Level $30.12 $282.49
Resistance Level $32.45 $354.87
Average True Range (ATR) 0.55 19.10
MACD 0.29 3.67
Stochastic Oscillator 96.32 86.31

Price Performance

Historical Comparison
AMH
PRAX

About AMH American Homes 4 Rent of Beneficial Interest

American Homes 4 Rent is a real estate investment trust focused on acquiring, operating, and leasing single-family homes as rental properties throughout the United States. The company's real estate portfolio is largely comprised of single-family properties in urban markets in the Southern and Midwestern regions of the U.S. American Homes 4 Rent's land holdings also represent a sizable percentage of its total assets in terms of value. The company derives the vast majority of its income in the form of rental revenue from single-family properties through short-term or annual leases. The firm's geographical markets include Dallas, Texas; Indianapolis, Indiana; Atlanta, Georgia; and Charlotte, North Carolina in terms of the number of properties in each.

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

Share on Social Networks: